B3GNT5 and central nervous system cancer: We compared the levels of B3GNT5 mRNA expression in normal human astrocytes (NHAs), glioma cell lines (A172, A1207, U87MG, and LN229), and patient‐derived GSCs (GSC11, 20, 23, and 267) (Figure 2A).